Zepdon
Indicated to target viral replication in HIV management formulated to mitigate disease progression.
- Category
- HIV Management
- Active ingredient
- Raltegravir
- Supply
- Rx
- Route
- Oral use
- Form
- Tablet
- Strengths
- 400mg
Zepdon details
- Condition
- HIV Infection
- Alternative names
- Isentress
- Therapeutic class
- Integrase Inhibitor
- Pharmacological class
- Integrase Inhibitor
- Contraindications
- hypersensitivity to raltegravir
- Precautions and warnings
- monitor for muscle pain; report any signs of rash
- Minor side effects
- headache; fatigue; nausea
- Moderate side effects
- insomnia; abdominal pain
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription only (specially controlled medicine)
- Manufacturer
- Natco Pharma
- Onset Time
- 1–2 hours
- Duration
- 12 hours
- Storage instructions
- Store at room temperature in a dry place.
- Drug interactions
- Rifampicin; Antacids
- Age restrictions
- Suitable for adolescents and adults.
Serious side effects
rhabdomyolysis, requires immediate medical attention; severe skin hypersensitivity reactions, requires immediate medical attention
Patient summary
Indicated to target viral replication in HIV management formulated to mitigate disease progression.
Mechanism of action
Raltegravir is an HIV-1 integrase strand transfer inhibitor that blocks the insertion of HIV DNA into the human genome, preventing the virus from replicating in host cells.
Pregnancy and breastfeeding
Pregnancy: Use recommended by specialist only. Breastfeeding: Advise against breastfeeding due to potential viral transmission.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Zepdon
Zepdon contains raltegravir, an antiretroviral medication used to manage HIV infection. Widely known under the brand name Isentress, this integrase inhibitor is supplied as a 400mg tablet. Natco Pharma manufactures this version to offer a consistent, quality-assured alternative for patients requiring reliable access to their ongoing antiretroviral therapy.
Zepdon availability in Asia
Zepdon is registered across 13 markets including Thailand, Malaysia and the Philippines, with availability also in Indonesia, Taiwan and South Korea. Generic raltegravir, much of it made in India, is far more affordable than the original brand, providing an important access route for expats and others living far from a well-stocked pharmacy or specialist service. As with all antiretroviral treatments, this medicine is best used under the regular supervision of a doctor.